Literature DB >> 219931

Drug-induced peripheral neuropathies.

Z Argov, F L Mastaglia.   

Abstract

Review of the various drugs in current clinical use showed that over 50 of them may cause a purely sensory or mixed sensorimotor neuropathy. These include antimicrobials, such as isoniazid, ethambutol, ethionamide, nitrofurantoin, and metronidazole; antineoplastic agents, particularly vinca alkaloids; cardiovascular drugs, such as perhexiline and hydrallazine; hypnotics and psychotropics, notable methaqualone; antirheumatics, such as gold, indomethacin, and chloroquine; anticonvulsants, particularly phenytoin; and other drugs, including disulfiram, calcium carbimide, and dapsone. Patients receiving drug treatment who complain of paraesthesie, pain, muscle cramps, or other abnormal sensations and those without symptoms who are receiving drugs that are known or suspected to be neurotoxic should undergo neurological examination and studies of motor and sensory nerve conduction. This will allow the incidence of drug-induced peripheral neuropathy to be determined more precisely.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219931      PMCID: PMC1598252          DOI: 10.1136/bmj.1.6164.663

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  69 in total

1.  USE OF ETHOGLUCID IN TREATMENT OF ADVANCED MALIGNANT DISEASE.

Authors:  M R BOND; S D CLARKE; F E NEAL
Journal:  Br Med J       Date:  1964-04-11

2.  THE ANTIPYRIDOXINE EFFECT OF PENICILLAMINE IN MAN.

Authors:  I A JAFFE; K ALTMAN; P MERRYMAN
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

3.  Treatment of advanced cancer by extracorporeal perfusion and continuous intra-arterial infusion.

Authors:  G WESTBURY
Journal:  Proc R Soc Med       Date:  1962-08

4.  [Nervous complications of gold therapy; survey of the neurological and psychiatric symptoms; results of treatment with BAL].

Authors:  L J ENDTZ
Journal:  Rev Neurol (Paris)       Date:  1958-09       Impact factor: 2.607

5.  Optic and peripheral neuritis. Probable effect of prolonged chloramphenicol therapy.

Authors:  R J JOY; R SCALETTAR; D B SODEE
Journal:  JAMA       Date:  1960-08-13       Impact factor: 56.272

6.  Peripheral neuritis due to streptomycin.

Authors:  P J JANSSEN
Journal:  Am Rev Respir Dis       Date:  1960-05

7.  Polyneuritis occurring during hydralazine therapy; report of two cases and discussion of adverse reactions to hydralazine.

Authors:  W M KIRKENDALL; E B PAGE
Journal:  J Am Med Assoc       Date:  1958-05-24

8.  PYRIDOXAL KINASE OF HUMAN BRAIN AND ITS INHIBITION BY HYDRAZINE DERIVATIVES.

Authors:  D B McCormick; E E Snell
Journal:  Proc Natl Acad Sci U S A       Date:  1959-09       Impact factor: 11.205

9.  Peripheral neuropathy due to ethioniamide.

Authors:  G W POOLE; J SCHNEEWEISS
Journal:  Am Rev Respir Dis       Date:  1961-12

10.  Neurotoxicity due to thiouracil and thiourea derivatives; a case report.

Authors:  T F FRAWLEY; G F KOEPF
Journal:  J Clin Endocrinol Metab       Date:  1950-06       Impact factor: 5.958

View more
  19 in total

1.  Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.

Authors:  James Wang; Kyle A Udd; Aleksandra Vidisheva; Regina A Swift; Tanya M Spektor; Eric Bravin; Emad Ibrahim; Jonathan Treisman; Mohammed Masri; James R Berenson
Journal:  Support Care Cancer       Date:  2016-02-23       Impact factor: 3.603

2.  Peripheral neuropathy during treatment with almitrine.

Authors:  F Chedru; R Nodzenski; J F Dunand; G Amarenco; R Ghnassia; C Ciaudo-Lacroix; G Said
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

Review 3.  Adverse effects of antianxiety drugs.

Authors:  J G Edwards
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

4.  Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient.

Authors:  G Tsujimoto; Y Horai; T Ishizaki; K Itoh
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 5.  Phenytoin: neuroprotection or neurotoxicity?

Authors:  Jan M Keppel Hesselink; David J Kopsky
Journal:  Neurol Sci       Date:  2017-05-11       Impact factor: 3.307

Review 6.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 7.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

8.  Polyneuropathy due to polyangiitis overlap syndrome.

Authors:  L H Kortbeek; M W van Beek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

9.  A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodgkin's disease.

Authors:  D Cipriani; G Landonio; C Canepari
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

Review 10.  Drug-induced neurological disorders.

Authors:  R J Lane; P A Routledge
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.